Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jiri Lukas, Timothy Ring, and More

Premium

The Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen has hired Jiri Lukas as its new director.

Lukas currently is head of the Centre for Genotoxic Stress Research at the Danish Cancer Society. The Center for Protein Research launched in 2007 and, with the hiring of Lukas, is now preparing to expand its research activities, CPR research director Matthias Mann said in a statement.


Combimatrix this week said it has named Richard Ding and Joseph Limber to its board of directors, and that former president and CEO Amit Kumar, as well as Rigdon Currie and John Abeles, will not stand for reelection at its next stockholders meeting.

Ding is CEO of BioTheranostics, a molecular diagnostics test developer and lab, and formerly was vice president of strategy and business development at BioMérieux. Limber is president and CEO of Prometheus Laboratories, a pharmaceutical and diagnostics company focused on personalized medicine. He also previously was president and CEO of Aclara BioSciences, now called Monogram Biosciences.


Quest Diagnostics named Timothy Ring to serve on its board of directors three months ago, and in a recent filing with the Securities and Exchange Commission the company said it has appointed him to sit on its compensation committee and its quality, safety, and compliance committee.

Ring is chairman and CEO of C. R. Bard, a developer, manufacturer, and marketer of medical technologies.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more